Skip to main content

BioAhead – an innovative optimization algorithm for amino acid chain analytics


Globosoft GmbH aims to optimize the drug development process of drug manufacturers, enabling faster and more efficient development of drugs in Europe and worldwide. For this purpose, Globosoft GmbH has developed the innovative optimization algorithm called BioAhead to optimize acid chain analysis, as part of the protein structure modeling field. The innovation will create growth in terms of income and new job creation and have a high return on investment. The proposed model has a high potential for a fast up-take by the market, considering the savings in time and money and also a cloud technology that will make the model easy-to-use in any country. BioAhead adequately addresses issues related to the society. With faster and more accurate drug development processes, the society in Europe and world-wide can benefit from low- priced medicines, faster drug development and highly specialized medicines, which are currently too expensive for economic development.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 50 000,00
Am Steinacher Ufer Kreuz 22
90427 Nurnberg

See on map

Bayern Mittelfranken Nürnberg, Kreisfreie Stadt
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00